9-124013973-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_004789.4(LHX2):āc.133A>Gā(p.Ile45Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,460,526 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_004789.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LHX2 | NM_004789.4 | c.133A>G | p.Ile45Val | missense_variant | 2/5 | ENST00000373615.9 | NP_004780.3 | |
LHX2 | XM_006717323.4 | c.133A>G | p.Ile45Val | missense_variant | 2/6 | XP_006717386.1 | ||
LHX2 | XM_047424082.1 | c.133A>G | p.Ile45Val | missense_variant | 2/6 | XP_047280038.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LHX2 | ENST00000373615.9 | c.133A>G | p.Ile45Val | missense_variant | 2/5 | 1 | NM_004789.4 | ENSP00000362717 | P1 | |
LHX2 | ENST00000446480.5 | c.127A>G | p.Ile43Val | missense_variant | 2/5 | 2 | ENSP00000394978 | |||
LHX2 | ENST00000560961.2 | c.10A>G | p.Ile4Val | missense_variant | 2/3 | 3 | ENSP00000453448 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000403 AC: 1AN: 248322Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135004
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460526Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 726592
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 05, 2024 | The c.133A>G (p.I45V) alteration is located in exon 2 (coding exon 2) of the LHX2 gene. This alteration results from a A to G substitution at nucleotide position 133, causing the isoleucine (I) at amino acid position 45 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at